- Home
- TLX vs NOV Comparison
TLX vs NOV Comparison
Compare TLX & NOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLX
- NOV
- Stock Information
- Founded
- TLX 2015
- NOV 1862
- Country
- TLX Australia
- NOV United States
- Employees
- TLX N/A
- NOV N/A
- Industry
- TLX Biotechnology: Pharmaceutical Preparations
- NOV Metal Fabrications
- Sector
- TLX Health Care
- NOV Industrials
- Exchange
- TLX Nasdaq
- NOV Nasdaq
- Market Cap
- TLX 5.8B
- NOV 5.6B
- IPO Year
- TLX N/A
- NOV 1996
- Fundamental
- Price
- TLX $19.50
- NOV $15.12
- Analyst Decision
- TLX Strong Buy
- NOV Buy
- Analyst Count
- TLX 1
- NOV 16
- Target Price
- TLX $22.00
- NOV $19.60
- AVG Volume (30 Days)
- TLX 18.8K
- NOV 4.5M
- Earning Date
- TLX 01-01-0001
- NOV 02-04-2025
- Dividend Yield
- TLX N/A
- NOV 1.99%
- EPS Growth
- TLX N/A
- NOV N/A
- EPS
- TLX 0.09
- NOV 1.60
- Revenue
- TLX $484,687,790.00
- NOV $8,870,000,000.00
- Revenue This Year
- TLX N/A
- NOV $0.35
- Revenue Next Year
- TLX N/A
- NOV $3.17
- P/E Ratio
- TLX $209.40
- NOV $9.44
- Revenue Growth
- TLX 80.92
- NOV 3.34
- 52 Week Low
- TLX $14.01
- NOV $13.95
- 52 Week High
- TLX $20.00
- NOV $21.20
- Technical
- Relative Strength Index (RSI)
- TLX N/A
- NOV 47.68
- Support Level
- TLX N/A
- NOV $15.23
- Resistance Level
- TLX N/A
- NOV $16.30
- Average True Range (ATR)
- TLX 0.00
- NOV 0.58
- MACD
- TLX 0.00
- NOV -0.03
- Stochastic Oscillator
- TLX 0.00
- NOV 42.96
About TLX Telix Pharmaceuticals Limited American Depositary Shares
Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.
About NOV NOV Inc.
NOV (formerly National Oilwell Varco) is a leading supplier of oil and gas drilling rig equipment and products, such as downhole tools, drill pipe, and well casing. The company operates on a global scale, with international markets contributing nearly two thirds of its annual revenue.